<DOC>
	<DOCNO>NCT02923453</DOCNO>
	<brief_summary>Objective : We aim evaluate long term efficacy safety AG add-on therapy patient type 2 diabetes control conventional treatment . Materials Methods : A total 23 type 2 patient enrol study . Utilizing double-blind , crossover design , participant randomize receive either placebo American ginseng extract ( AG ) 1g/meal=3g/day 8-week , maintain conventional diabetes treatment . Following ≥4-week washout period participant cross another 8-week treatment arm . Throughout study period , individual maintain original diabetes treatment regular lifestyle . The primary endpoint HbA1c , secondary fasting blood glucose insulin , blood pressure , serum nitrates/nitrites ( NOx ) PAI-1 . Safety parameter include liver , kidney hemostatic function .</brief_summary>
	<brief_title>Effect Ginseng Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Presence type 2 diabetes ≥1 year duration BMI 2535kg/m^2 HbA1c 6.58.5 % Patients insulin therapy Impaired hepatic renal function Clinically manifest diabetic complication Present cardiac problem Uncontrolled hypoglycemia Cigarette smoker Alcohol consumption ( &gt; 2 drink per week ) Taking ginseng herb possible hypoglycemic effect Involvement investigational drug study Changed medication course study period washout period</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>